A vacuum-assisted excisional biopsy yielded multiple fibroadipose fragments measuring 2.7 x 2.3 x 0.5 cm in aggregate. Microscopic examination showed a part of a circumscribed nodule harboring benign glands and tubules composed of glandular epithelium along with myoepithelial cells in a background of variably fibrotic and chondromyxoid stroma (Figures 4-6), as well as an intraductal papilloma component in the vicinity (Figure 7). Although the presence of chondromyxoid stroma might have suggested the differential diagnosis of metaplastic carcinoma, the lack of atypia or even hypercellularity in both epithelial and stromal components negated that differential. Immunohistochemistry showed expression of Smooth Muscle Myosin, p63, S-100, GFAP and CK 5/6 in myoepithelial cells while glandular epithelial cells expressed CK 7 (Figure 8). A diagnosis of pleomorphic adenoma of breast with associated intraductal papilloma was established. The patient had no further interventions. During a follow up hospital visit more than a year later, the patient had no breast-related complaints.
The physical examination revealed a hard swelling involving the left breast area, extending up to the nipple but not adherent to the skin or underlying chest wall.
MRI of the breast showed a large, bulging, and lobulated mass measuring 9.5 x 6.5 x 6 cm, located in the left breast with no associated skin edema/thickening. The mass abutted and partly compressed the underlying pectoral muscle without signs of muscle infiltration, and showed rim enhancement with washout and necrosis in the lateral aspect. The mass was given a score of BI-RADS 4 with rapidly growing phyllodes tumor cited as the main differential diagnosis. A core biopsy from the mass revealed mixed benign myoepithelial and glandular epithelial cells surrounded by chondromyxoid stroma with prominent cartilaginous differentiation. The cartilaginous areas showed no features of atypia, and neither did the epithelial parts, which ruled out a possible differential diagnosis of metaplastic carcinoma. By immunohistochemistry the myoepithelial cells expressed Smooth Muscle Myosin, p63 and CK5/6; glandular epithelial cells expressed CKAE1/ AE3; stromal cells expressed GFAP; and cartilaginous cells in stroma expressed S100. Estrogen Receptor (ER) and Smooth Muscle Actin (SMA) were negative. The subsequent excision specimen contained a lobulated mass measuring 9 x 8 x 3 cm with a partially red to yellow and partially tan-white calcified cut surface. Several areas revealed bluish-white coloration indicating cartilaginous differentiation (Figure 1). Microscopically this mass showed identical histology to the biopsy (Figures 2, 3); no immunohistochemistry was performed on the excision specimen and the diagnosis remained the same in both specimens as pleomorphic adenoma of the breast.
Table I: Reported cases of breast and nipple pleomorphic adenomas in male patients.
PABs are among the so-called salivary gland-type mammary tumors [1], a heterogeneous group of tumors that are usually subclassified into epithelial, myoepithelial and epithelial-myoepithelial morphologic subtypes (i.e., biphasic); the last of which includes PABs among others [3]. The majority manifest clinically as a palpated retroareolar solitary lump [2]. Diagnostic imaging findings varied significantly among authors, with some reporting fibroadenoma-like appearance that may harbor macrocalcifications [3], while others reported features ranging from completely calcified fibroadenomas to those suggesting carcinomas and mucinous carcinomas [4]. Our patients also manifested this variety, with the first patient having a palpable mass expressing radiologic features of phyllodes tumor; while the second patient had asymptomatic lesion that was only described by radiology as a complex cyst. The rarity of PABs in the literature has made it extremely difficult to establish a diagnosis even on core biopsies, with a lot of cases being misdiagnosed as carcinoma [4]. The differential diagnosis for PABs is a wide list, with metaplastic carcinomas at the top of the list as the most worrisome possibility. The latter, along with matrixproducing carcinomas must all be excluded, a challenging task in core biopsies. While the presence of unequivocal features of malignancy (like severe nuclear atypia, absence of myoepithelial cells and abundant mitotic activity among others) favors the diagnosis of carcinoma, the absence of those features in core biopsies does not negate malignancy elsewhere in the lesion as many cases were found to be malignant only after excision and examining the entire lesion [1,3].
This has made surgery the mainstay of diagnosis and management, with local excision and subsequent histological examination of the specimen serving as the best way to reach an accurate diagnosis [5]. Gross examination of PAB usually yields a well-demarcated lesion that measures around 2 cm in maximum dimension [3]. Microscopically PABs resemble salivary gland pleomorphic adenomas with a cellular component composed of cords and glandular formations of epithelial and myoepithelial cells embedded in a variable chondro-myxoid stromal component [3]. An intraductal papilloma is often seen in the vicinity of PAB, which led many authors to consider them a variant of papilloma, while other authors associated PABs with other benign neoplasms like ductal adenomas [1]. This feature was expressed in the PAB of our second patient, which featured a microscopic intraductal papilloma component. Immunohistochemically, PABs express SMA and S100 and GFAP in the myoepithelial cells and EMA and cytokeratin in the epithelial cells [5] while being negative for ER, PR and Her-2 (triple-negative) [1]. Salivary pleomorphic adenomas express translocations in chromosomes affecting genes PLAG1, HMGI-C and HMGIY. Immunohistochemical expression of HMGI-C and HMGIY have been reported, but more research studying the genetics of PABs is needed [2].
PABs express mainly a benign clinical course, even with reports of cases recurring locally [3]. Carcinoma ex pleomorphic adenoma is the term describing malignant transformation of PAB, an extremely exceptional complication that has only been reported three times before [3]. Because of this slim malignant transformation potential, some authors proposed annual follow up extending to five years in PAB cases.
CONFLICT of INTEREST
The authors declare no conflict of interest.
AUTHORSHIP CONTRIBUTIONS
Concept: All authors contributed, Design: OE, MA,
KAS, Data collection or processing: OE, HAS, Analysis or
Interpretation: All authors contributed, Literature search:
OE, KAS, Writing: OE, Akhtar, Approval: MA.
1) Rakha EA, Aleskandarany MA, Samaka RM, Hodi Z, Lee AH,
Ellis IO. Pleomorphic adenoma‐like tumour of the breast.
Histopathology. 2016; 68:405-10.
2) Han Y, Zhang Q, Li SX, Feng L, Zhang L, Li Z, Qiu X, Jin F,
Chen B. Case report pleomorphic adenoma of the breast: A
report of two cases and a literature review. Int J Clin Exp Pathol.
2016;9:2459-65.
3) Foschini MP, Krausz T. Salivary gland-type tumors of the breast:
A spectrum of benign and malignant tumors including triple
negative carcinomas of low malignant potential. Semin Diagn
Pathol. 2010;27:77-90.
4) Mizukami Y, Takayama T, Takemura A, Ichikawa K, Onoguchi
M, Miyati T, Taniya T. Pleomorphic adenoma of the breast.
Radiat Med. 2008;26:442-5.
5) Shah AK, Venkatesan S, Katoch R, Jaiswal SS, Gambhir RP,
Bhardwaj R. Epithelial-myoepithelial carcinoma ex pleomorphic
adenoma in breast: An exotic rarity. Med J Armed Forces India.
2011;67:74-6.
6) Ballance WA, Ro JY, el-Naggar AK, Grignon DJ, Ayala AG,
Romsdahl MG. Pleomorphic adenoma (benign mixed tumor)
of the breast. An immunohistochemical, flow cytometric, and
ultrastructural study and review of the literature. Am J Clin
Pathol. 1990;93:795-801.
7) Makek M, Von Hochstetter AR. Pleomorphic adenoma of the
human breast. J Surg Oncol. 1980;14:281-6.
8) Simha MR, Doctor VM, Udwadia TE. Mixed tumour of salivary
gland type of the male breast. Indian J Cancer. 1992;29:14-7.
9) Butrón M, y Cajal SR, Moreno A, García-Andrade С, Rivas С,
Oliva H. Pleomorphic adenoma of male breast: Report of a case
and review of the literature. Rev Esp Patol. 1997;30:232-7.